Prolyl oligopeptidase, inositol phosphate signalling and lithium sensitivity

CNS and Neurological Disorders - Drug Targets

Volumn 10, Issue 3, 2011, Pages 333-339

  Harwood, Adrian J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Bipolar mood disorder; Dictyostelium; Inositol phosphate signalling; Lithium; Multiple inositol polyphosphate phosphatase; Prolyl oligopeptidase

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3; INOSITOL PHOSPHATE; LITHIUM; PROLYL ENDOPEPTIDASE;

BACTERIAL GENE; DICTYOSTELIUM; GENE CONTROL; GENE EXPRESSION; HUMAN; MENTAL HEALTH; NONHUMAN; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION;

EID: 79951696069     PISSN: 18715273     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152711794653779     Document Type: Review

References (58)

1. Hallcher, L.M.; Sherman, W.R. The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J. Biol. Chem., 1980, 255(22), 10896-10901.
2. Berridge, M.J. Inositol trisphosphate and calcium signaling mechanisms. Biochim. Biophys. Acta, 2009, 1793(6), 933-940.
3. Cantley, L.C. The phosphoinositide 3-kinase pathway. Science, 2002, 296, 1655-1657.
4. Di Paolo, G.; De Camilli, P. Phosphoinositides in cell regulation and membrane dynamics. Nature, 2006, 443, 651-657.
5. Inhorn, R.C.; Majerus, P.W. Properties of inositol polyphosphate 1 phosphatase. J. Biol. Chem., 1988, 263(28), 14559-14565.
6. Harwood, A.J. Lithium and bipolar mood disorder: the inositoldepletion hypothesis revisited. Mol. Psychiatry, 2005, 10(1), 117-126.
7. van Calker, D.; Belmaker, R.H. The high affinity inositol transport system--implications for the pathophysiology and treatment of bipolar disorder. Bipolar Disord., 2000, 2, 102-107.
8. Mikoshiba, K. Inositol 1,4,5-trisphosphate receptor. Trends Pharmacol. Sci., 1993, 14, 86-89.
9. Hokin, L.E. Lithium increases accumulation of second messenger inositol 1,4,5-trisphosphate in brain cortex slices in species ranging from mouse to monkey. Adv. Enzyme Regul., 1993, 33, 299-312.
10. Dixon, J.F.; Hokin, L.E. Lithium acutely inhibits and chronically up-regulates and stabilizes glutamate uptake by presynaptic nerve endings in mouse cerebral cortex. Proc. Natl. Acad. Sci. USA, 1998, 95(14), 8363-8368.
11. Czech, M.P. PIP2 and PIP3: complex roles at the cell surface. Cell, 2000, 100(6), 603-606.
12. Tanaka, K.; Adachi, H.; Konishi, H.; Iwamatsu, A.; Ohkawa, K.; Shirai, T.; Nagata, S.; Kikkawa, U.; Fukui, Y. Identification of protein kinase B (PKB) as a phosphatidylinositol 3,4,5-trisphosphate binding protein in Dictyostelium discoideum. Biosci. Biotechnol. Biochem., 1999, 63(2), 368-372.
13. Storz, P.; Toker, A. 3'-phosphoinositide-dependent kinase-1 (PDK-1) in PI 3-kinase signaling. Front. Biosci., 2002, 7, d886-d902.
14. King, J.S.; Teo, R.; Ryves, J.; Reddy, J.V.; Peters, O.; Orabi, B.; Hoeller, O.; Williams, R.S.; Harwood, A.J. The mood stabilizer lithium suppresses PIP3 signalling in Dictyostelium and human cells. Dis. Model Mech., 2009, 2, 306-312.
15. Kessin, R.H. Dictyostelium Evolution, Cell Biology, and the Development of Multi cellularity. Cambridge University Press: Cambridge, UK, 2001; p. 14+294.
16. Hoeller, O.; Kay, R.R. Chemotaxis in the absence of PIP3 gradients. Curr. Biol., 2007, 17, 813-817.
17. Takeda, K.; Sasaki, A.T.; Ha, H.; Seung, H.A.; Firtel, R.A. Role of phosphatidylinositol 3-kinases in chemotaxis in Dictyostelium. J. Biol. Chem., 2007, 282(16), 11874-11884.
18. Force, T.; Woodgett, J.R. Unique and overlapping functions of GSK-3 isoforms in cell differentiation and proliferation and cardiovascular development. J. Biol. Chem., 2009, 284(15), 9643-9647.
19. Klein, P.S.; Melton, D.A. A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. USA, 1996, 93(16), 8455-8459.
20. Ryves, W.J.; Harwood, A.J. Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochem. Biophys. Res. Commun., 2001, 280, 720-725.
21. Ryves, W.J.; Dajani, R.; Pearl, L.; Harwood, A.J. Glycogen synthase kinase-3 inhibition by lithium and beryllium suggests the presence of two magnesium binding sites. Biochem. Biophys. Res. Commun., 2002, 290, 967-972.
22. Masuda, C.A.; Xavier, M.A.; Mattos, K.A.; Galina, A.; Montero-Lomeli, M. Phosphoglucomutase is an in vivo lithium target in yeast. J. Biol. Chem., 2001, 276, 37794-37801.
23. Beaulieu, J.M.; Marion, S.; Rodriguiz, R.M.; Medvedev, I.O.; Sotnikova, T.D.; Ghisi, V.; Wetsel, W.C.; Lefkowitz, R.J.; Gainetdinov, R.R.; Caron, M.G. A beta-arrestin 2 signaling complex mediates lithium action on behavior. Cell, 2008, 132, 125-136.
24. Chalecka-Franaszek, E.; Chuang, D.M. Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proc. Natl. Acad. Sci. USA, 1999, 96, 8745-8750.
25. Zhang, F.; Phiel, C.J.; Spece, L.; Gurvich, N.; Klein, P.S. Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium: evidence for autoregulation of GSK-3. J. Biol. Chem., 2003, 278, 33067-33077.
26. Szatmari, E.; Habas, A.; Yang, P.; Zheng, J.J.; Hagg, T.; Hetman, M. A positive feedback loop between glycogen synthase kinase 3beta and protein phosphatase 1 after stimulation of NR2B NMDA receptors in forebrain neurons. J. Biol. Chem., 2005, 280, 37526-37535.
27. Williams, R.S.; Eames, M.; Ryves, W.J.; Viggars, J.; Harwood, A.J. Loss of a prolyl oligopeptidase confers resistance to lithium by elevation of inositol (1,4,5) trisphosphate. EMBO J., 1999, 18(10), 2734-2745.
28. Harwood, A.J.; Plyte, S.E.; Woodgett, J.; Strutt, H.; Kay, R.R. Glycogen synthase kinase 3 regulates cell fate in Dictyostelium. Cell, 1995, 80(1), 139-148.
29. Teo, R.; Lewis, K.J.; Forde, J.E.; Ryves, W.J.; Reddy, J.V.; Rogers, B.J.; Harwood, A.J. Glycogen Synthase Kinase-3 (GSK3) is required for efficient Dictyostelium chemotaxis. Mol. Biol. Cell, 2010, 21, 2788-2796.
30. Brandt, I.; De Vriendt, K.; Devreese, B.; Van Beeumen, J.; Van Dongen, W.; Augustyns, K.; De Meester, I.; Scharpe, S.; Lambeir, A.M. Search for substrates for prolyl oligopeptidase in porcine brain. Peptides, 2005, 26, 2536-2546.
31. Drayer, A.L.; Van der Kaay, J.; Mayr, G.W.; Van Haastert, P.J.M. Role of phospholipase C in Dictyostelium formation of inositol 1,4,5-trisphosphate and normal development in cells lacking phospholipase C activity. EMBO J., 1994, 13, 1601-1609.
32. + signalling is not required for chemotaxis in Dictyostelium. EMBO J., 2000, 19(17), 4846-4854.
33. Van Dijken, P.; De Haas, J.R.; Craxton, A.; Erneux, C.; Shears, S.B.; Van Haastert, P.J.M. A novel, phospholipase C-independent pathway of inositol 1, 4,5-trisphosphate formation in Dictyostelium and rat liver. J. Biol. Chem., 1995, 270, 29724-29731.
34. Craxton, A.; Caffrey, J.J.; Burkhart, W.; Safrany, S.T.; Shears, S.B. Molecular cloning and expression of a rat hepatic multiple inositol polyphosphate phosphatase. Biochem. J., 1997, 328, 75-81.
35. King, J.; Keim, M.; Teo, R.; Weening, K.E.; Kapur, M.; McQuillan, K.; Ryves, J.; Rogers, B.; Dalton, E.; Williams, R.S.; Harwood, A.J. Genetic control of lithium sensitivity and regulation of inositol biosynthetic genes. PLoS One, 2010, 5, e11151.
36. Cho, J.; King, J.S.; Qian, X.; Harwood, A.J.; Shears, S.B. Dephosphorylation of 2, 3-bisphosphoglycerate by MIPP expands the regulatory capacity of the Rapoport-Luebering glycolytic shunt. Proc. Natl. Acad. Sci. USA, 2008, 105, 5998-6003.
37. Benesch, R.; Benesch, R.E.; Enoki, Y. The interaction of hemoglobin and its subunits with 2, 3-diphosphoglycerate. Proc. Natl. Acad. Sci. USA, 1968, 61, 1102-1106.
38. Benesch, R.; Benesch, R.E.; Yu, C.I. Reciprocal binding of oxygen and diphosphoglycerate by human hemoglobin. Proc. Natl. Acad. Sci. USA, 1968, 59, 526-532.
39. Atack, J.R.; Broughton, H.B.; Pollack, S.J. Structure and mechanism of inositol monophosphatase. FEBS Lett., 1995, 361, 1-7.
40. Steger, D.J.; Haswell, E.S.; Miller, A.L.; Wente, S.R.; O'Shea, E.K. Regulation of chromatin remodeling by inositol polyphosphates. Science, 2003, 299, 114-116.
41. Gao, Y.; Wang, H.Y. Inositol pentakisphosphate mediates Wnt/beta-catenin signaling. J. Biol. Chem., 2007, 282, 26490-26502.
42. Shen, X.; Xiao, H.; Ranallo, R.; Wu, W.H.; Wu, C. Modulation of ATP-dependent chromatin-remodeling complexes by inositol polyphosphates. Science, 2003, 299, 112-114.
43. Myohanen, T.T.; Venalainen, J.I.; Garcia-Horsman, J.A.; Piltonen, M.; Mannisto, P.T. Cellular and subcellular distribution of rat brain prolyl oligopeptidase and its association with specific neuronal neurotransmitters. J. Comp. Neurol., 2008, 507, 1694-1708.
44. Myohanen, T.T.; Venalainen, J.I.; Tupala, E.; Garcia-Horsman, J.A.; Miettinen, R.; Mannisto, P.T. Distribution of immunoreactive prolyl oligopeptidase in human and rat brain. Neurochem. Res., 2007, 32, 1365-1374.
45. Myohanen, T.T.; Venalainen, J.I.; Garcia-Horsman, J.A.; Mannisto, P.T. Spatial association of prolyl oligopeptidase, inositol 1,4,5-triphosphate type 1 receptor, substance P and its neurokinin-1 receptor in the rat brain: an immunohistochemical colocalization study. Neuroscience, 2008, 153, 1177-1189.
46. Schulz, I.; Gerhartz, B.; Neubauer, A.; Holloschi, A.; Heiser, U.; Hafner, M.; Demuth, H.U. Modulation of inositol 1,4,5-triphosphate concentration by prolyl endopeptidase inhibition. Eur. J. Biochem., 2002, 269, 5813-5820.
47. Williams, R.S.; Cheng, L.; Mudge, A.W.; Harwood, A.J. A common mechanism of action for three mood stabilizing drugs. Nature, 2002, 417, 292-295.
48. Sarkar, S.; Floto, R.A.; Berger, Z.; Imarisio, S.; Cordenier, A.; Pasco, M.; Cook, L.J.; Rubinsztein, D.C. Lithium induces autophagy by inhibiting inositol monophosphatase. J. Cell Biol., 2005, 170, 1101-1111.
49. Moreno-Baylach, M.J.; Puttonen, K.A.; Tenorio-Laranga, J.; Venäläinen, J.S.M.; Forsberg, M.M.; García-Horsman, A.J. Prolyl oligopeptidase is involved in the cellular signalling in human neuroblastoma SHSY5Y cells. Neurosignals, 2011, in press.
50. Maes, M.; Goossens, F.; Scharpe, S.; Meltzer, H.Y.; D'Hondt, P.; Cosyns, P. Lower serum prolyl endopeptidase enzyme activity in major depression: further evidence that peptidases play a role in the pathophysiology of depression. Biol. Psychiatry, 1994, 35, 545-552.
51. Maes, M.; Goossens, F.; Scharpe, S.; Calabrese, J.; Desnyder, R.; Meltzer, H.Y. Alterations in plasma prolyl endopeptidase activity in depression, mania, and schizophrenia: effects of antidepressants, mood stabilizers, and antipsychotic drugs. Psychiatry Res., 1995, 58, 217-225.
52. Breen, G.; Harwood, A.J.; Gregory, K.; Sinclair, M.; Collier, D.; St Clair, D.; Williams, R.S. Two peptidase activities decrease in treated bipolar disorder not schizophrenic patients. Bipolar Disord., 2004, 6, 156-161.
53. Van Gool, A.R.; Van Ojik, H.H.; Kruit, W.H.; Mulder, P.G.; Fekkes, D.; Bannink, M.; Scharpe, S.; Stoter, G.; Eggermont, A.M.; Maes, M.; Verkerk, R. Serum activity of prolyl endopeptidase, but not of dipeptidyl peptidase IV, is decreased by immunotherapy with IFN-alpha in high-risk melanoma patients. J. Interferon Cytokine Res., 2004, 24, 411-415.
54. Padmos, R.C.; Hillegers, M.H.; Knijff, E.M.; Vonk, R.; Bouvy, A.; Staal, F.J.; de Ridder, D.; Kupka, R.W.; Nolen, W.A.; Drexhage, H.A. A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Arch. Gen. Psychiatry, 2008, 65, 395-407.
55. Sjoholt, G.; Gulbrandsen, A.K.; Lovlie, R.; Berle, J.O.; Molven, A.; Steen, V.M. A human myo-inositol monophosphatase gene (IMPA2) localized in a putative susceptibility region for bipolar disorder on chromosome 18p11.2: genomic structure and polymorphism screening in manic-depressive patients. Mol. Psychiatry, 2000, 5, 172-180.
56. Sjoholt, G.; Ebstein, R.P.; Lie, R.T.; Berle, J.O.; Mallet, J.; Deleuze, J.F.; Levinson, D.F.; Laurent, C.; Mujahed, M.; Bannoura, I.; Murad, I.; Molven, A.; Steen, V.M. Examination of IMPA1 and IMPA2 genes in manic-depressive patients: association between IMPA2 promoter polymorphisms and bipolar disorder. Mol. Psychiatry, 2004, 9, 621-629.
57. Ohnishi, T.; Yamada, K.; Ohba, H.; Iwayama, Y.; Toyota, T.; Hattori, E.; Inada, T.; Kunugi, H.; Tatsumi, M.; Ozaki, N.; Iwata, N.; Sakamoto, K.; Iijima, Y.; Iwata, Y.; Tsuchiya, K.J.; Sugihara, G.; Nanko, S.; Osumi, N.; Detera-Wadleigh, S.D.; Kato, T.; Yoshikawa, T. A promoter haplotype of the inositol monophosphatase 2 gene (IMPA2) at 18p11.2 confers a possible risk for bipolar disorder by enhancing transcription. Neuropsychopharmacology, 2007, 32, 1727-1737.
58. Mamdani, F.; Sequeira, A.; Alda, M.; Grof, P.; Rouleau, G.; Turecki, G. No association between the PREP gene and lithium responsive bipolar disorder. BMC Psychiatry, 2007, 7, 9.